Daunorubicin and atrial fibrillation Patient Reports February 11, 2012

Daunorubicin Side Effects Report #4681529-8
Daunorubicin side effect was reported by a Health Professional from on May 19, 2005. Female patient, 72 years of age, weighting 173.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atrial fibrillation , heart rate increased, myocardial ischaemia. Daunorubicin dosage: 45MG/2 OTHER. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4970510-7
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on Apr 11, 2006. Female patient, 55 years of age, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain upper, angiopathy, atrial fibrillation , cardiac ventricular disorder, coagulopathy, cough, depressed level of consciousness, dilatation ventricular, dyspnoea. Daunorubicin dosage: 90 MG /M2 DAILY FOR 3 DAYS IV. During the same period patient was treated with CYTARABINE, CASPOFUNGIN, VANCOMYCIN, CIPROFLOXACIN, LASIX. Patient recovered.

Daunorubicin Side Effects Report #4590819-9
Daunorubicin side effect was reported by a Consumer or non-health professional from on Feb 22, 2005. Male patient, weighting 152.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atrial fibrillation , haematochezia, haematocrit decreased, haemoglobin decreased, haemorrhage, hypotension, pyrexia, sinus tachycardia. Daunorubicin dosage: 60 MG/M2/DAY BY IVP. During the same period patient was treated with CYTARABINE. Patient recovered.

Daunorubicin Side Effects Report #4805956-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2005. Female patient, weighting 202.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atrial fibrillation , chest pain , electrocardiogram t wave abnormal, haemodynamic instability, hypotension, hypoxia, infection , pericardial effusion, pericarditis. Daunorubicin dosage: unknown. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.


Daunorubicin Side Effects Report #4805962-6
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2005. Female patient, weighting 202.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atrial fibrillation , chest pain , electrocardiogram t wave abnormal, haemodynamic instability, hypotension, hypoxia, infection , pericardial effusion, pericarditis. Daunorubicin dosage: unknown. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4788066-0
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on Oct 04, 2005. Female patient, 55 years of age, weighting 169.0 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atrial fibrillation , body temperature increased, constipation , hypotension, ileus, neutropenia, ventricular extrasystoles. Daunorubicin dosage: 108MG IV WEEKLY. During the same period patient was treated with ACYCLOVIR, FAMOTIDINE, FENTANYL, MEROPENEM. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4797401-9
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2005. Female patient, 55 years of age, weighting 169.0 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atrial fibrillation , dyspnoea, escherichia bacteraemia, hypoxia, metabolic acidosis, rales, renal failure acute, respiratory failure. Daunorubicin dosage: 108MG IV WEEKLY. During the same period patient was treated with ACYCLOVIR, AMPHOGEL, MEROPENEM. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4788090-8
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atrial fibrillation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4799935-X
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation , blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.


Daunorubicin Side Effects Report #4799940-3
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: arrhythmia , atrial fibrillation , hypocalcaemia, hypotension, tachycardia. Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4799942-7
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation , blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4799946-4
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation , blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.